Actively Recruiting
Remote Patient Monitoring Solution for Chronic Respiratory Disease Management
Led by SingHealth Polyclinics · Updated on 2025-05-15
180
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the AeviceMD Monitoring System for asthma to see if it can reduce acute exacerbations and improve outcomes such as quality of life, self-efficacy, and cost-effectiveness. This study involves both pediatric patients aged 7 and older and adults, with a follow-up period of three months. It also assesses the usability of the device from both patients' and clinicians' perspectives to understand its practical application in asthma management. Participants are randomly assigned to two groups: one receives standard care which includes nurse telephone follow-ups and doctor visits along with an asthma action plan, while the other group receives the AeviceMD device in addition to standard care. The device is used mainly at night for at least five hours but can be used anytime. AeviceMD records breathing rates and lung sounds, providing patients with objective lung data to help manage asthma symptoms and share with their clinicians during follow-ups. Throughout the 12-week study, participants will be monitored with various assessments including rescue therapy use, oral Prednisolone dose, emergency visits, hospitalizations, and quality of life questionnaires. The study also tracks self-efficacy, device usage, and clinician feedback. Participants will return the device after the study, and researchers will evaluate the impact on asthma control and healthcare utilization to understand the device's role in improving asthma management.
CONDITIONS
Brief Title
Remote Patient Monitoring Solution for Chronic Respiratory Disease Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of asthma
- Pediatric patients aged 7 to 17 years or adult patients aged 18 years and above
- Have an asthma exacerbation on the day of visit
- Willing to use the AeviceMD device
- Own a smartphone to download the AeviceMD application
- Have Wi-Fi connection to use with AeviceMD
- Able to communicate in English
You will not qualify if you...
- No capacity to provide consent
- Concurrent chronic obstructive pulmonary disease (COPD)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for eligibility assessment and consent
Duration - 12 weeks
Participants in the intervention group receive the AeviceMD device and training on its use. They use the device to monitor their respiratory rate and lung sounds to help self-manage their asthma following their asthma action plan.
Device provided at baseline visit; participants use device daily as preferred
Duration - Up to 12 weeks
Participants receive standard care from the Polyclinic including a telephone follow-up by a nurse within 5 days and a follow-up visit with a doctor after one week. Asthma symptoms and management are reviewed during these contacts.
1 telephone nurse follow-up and 1 in-person doctor visit
Trial Site Locations
Total: 1 location
1
SingHealth Polyclinics
Singapore, Singapore, 150167
Actively Recruiting
Research Team
M
Mabel QH Leow, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here